Ovarian Carcinomas: Clinicopathologic and Molecular Features With Comments on 2014 FIGO Staging.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39807827.
- Also identified by DOI 10.1097/PAS.0000000000002352.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
According to histopathology and molecular genetics, there are 5 major subtypes of ovarian carcinomas: high-grade serous (70%), endometrioid (10%), clear cell (10%), mucinous (3% to 4%), and low-grade serous (<5%) carcinomas. These tumors, which constitute over 95% of cases, represent distinct diseases with different prognoses and therapy. This review outlines contemporary advances in molecular pathology, which have expanded our knowledge of the biology of epithelial ovarian cancer and are also important to patient management. We also comment on some controversial points of the FIGO staging classification that we proposed in 2014.
Medical subject headings
- Ovarian Neoplasms
- Biomarkers, Tumor